Prospective Study To Evaluate The Safety And Efficacy Of ICath Device In Illuminated Microcatheter Assisted Transluminal Trabeculotomy (iMAT) Versus Combined Trabeculotomy And Trabeculectomy In Patients With Primary Congenital Glaucoma

The most common cause of glaucoma in the pediatric population is primary congenital glaucoma (PCG) which can have devasting visual consequences.The management is surgical and to create fluid outflow pathway by surgeries including goniotomy and trabeculotomy or trabeculectomy. Specifically in cases of hazy corneas, combined trabeculotomy with trabeculectomy ab externo is the preferred initial surgery

Illuminated microcatheter assisted trabeculotomy has emerged as a good surgical alternative with improved success rates compared to conventional CTT. The lighted tip to guide the catheter minimizes potentially devasting inadvertent misdirection into the suprachoroidal or subretinal space by verification of the microcatheter location within Schlemm’s canal.

The purpose of this study is to evaluate the safety and efficacy of ICath device for Illuminated Microcatheter Assisted Transluminal Trabeculotomy (iMAT) and compare with Combined Trabeculotomy and Trabeculectomy in patients with Primary Congenital Glaucoma.

The objective of the study is to evaluate the safety and efficacy of  I Cath device using Illuminated Microcatheter Assisted Transluminal Trabeculotomy (iMAT) compared Combined Trabeculotomy and Trabeculectomy in patients with Primary Congenital Glaucoma. The study will include treatment Naïve PCG children, with no central corneal scar or cleft and corneal diameter not greater than 13 mm.